Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024
Published Date: 02-Jan-2019Healthcare
Category: Report Format : PDF
Report Code: ZMR-3690
Status : Published
Global sterile injectable drugs market expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024. The increasing preference for large molecule drugs over traditional drugs, rising incidences of chronic diseases fueling the global market.